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1 
Abstract 
We examined and compared the relationship between religiosity and symptom severity 
in patients with major depressive disorder (MDD; rated by the Hamilton Depression 
Rating Scale) and schizophrenia (Positive and Negative Syndrome Scale). Duke 
University Religion index, Santa Clara Strength of Religious Faith (SCSORF) 
questionnaire and Brief Religious Coping scale scores were similar between MDD (n=50) 
and schizophrenia (n=50) patients. In MDD patients, higher organized religious activity 
(ORA) (estimate=2.28, 95%CI 0.37, 4.19; P=0.020) and higher negative religious coping 
(estimate=0.43, 95%CI 0.03, 0.84; P=0.037) were independently associated with more 
severe symptoms. In schizophrenia patients, higher ORA was associated with lower 
negative symptoms (estimate=-1.99, 95%CI -3.94, -0.03; P=0.046). Higher SCSORF was 
associated with lower ORA in both patient subsets, and thus indirectly with milder 
symptoms in MDD patients and with more severe negative symptoms in schizophrenia 
patients. The relationship between religiosity and symptom severity apparently differs 
in patients with MDD and schizophrenia. 
 
Key words: Religiosity, Religious coping, Major depressive disorder, Schizophrenia 
 
 
 
 
 
 
 
 
2 
Introduction 
There is a considerable body of evidence that spirituality, religious beliefs and practices 
may be important resources for coping with stress, somatic and mental illnesses 
(Koenig, 2009; Bonelli & Koenig, 2013; Aldwin et al., 2014). In health care research, 
spirituality and religiousness are commonly used complementarily or synonymously to 
depict a multidimensional construct of addressing the transcendent (Koenig, 2009), 
although the two concepts differ in that religiousness is depicted by specific behavioural 
and social elements such as religious service attendance and affiliation, while spirituality 
refers to feelings of self-transcendence and subjective experiences that do not 
necessarily need to be related to any religious denomination (Aldwin et al., 2014).  
In respect to mental health, higher level of religiosity is generally considered beneficial, 
as it is associated with increased life satisfaction, happiness, higher morale and positive 
mood (Moreira-Almeida et al., 2006). A systematic review of quantitative research 
published in the top 25% psychiatry journals between 1990 and 2010 concluded that 
there was good evidence for a conclusion that higher spirituality/religiousness was 
associated with lower prevalence of depressive disorders in general population or in 
medically ill patients, as well as with less severe symptoms in patients suffering from 
depressive disorders (Bonelli & Koenig, 2013). In respect to psychotic disorders, 
however, the relationship seems to be a more complex one. A rather high proportion of 
patients with schizophrenia experience religious delusions and/or hallucinations. Their 
prevalence and content may greatly vary across specific cultural, social and religious 
settings, and may be associated with a poorer prognosis (Koenig, 2009; Grover et al., 
2014). High quality studies are considerably fewer than those pertaining to depression. 
Some have indicated a greater risk of transient psychotic disorders in subjects with 
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intensive religious experiences, while others (albeit not all) reported an association 
between a greater religious involvement and better treatment compliance or higher 
well-being in patients with schizophrenia (Bonelli & Koenig, 2013). Data also suggests 
that higher religiosity is associated with a lower level of smoking and other substance 
abuse in these patients (Borras et al., 2008; Huguelet et al., 2009), and that in many 
patients with schizophrenia, spirituality/religiosity might be effectively used to cope 
with the illness and to improve quality of life (Grover et al., 2014).  
To the best of our knowledge, no study comparatively evaluated religiosity in patients 
with major depressive disorder (MDD) and patients with schizophrenia. We aimed to 
investigate the relationship between religiosity/positive and negative religious coping 
and symptom severity in inpatients with MDD and inpatients with schizophrenia 
“sampled” from the same cultural and social context and assessed within the same time-
frame, and to explore potential differences between the two disorders in the 
relationships between symptom severity and specific religious domains, such as positive 
and negative religious coping, organizational and non-organizational religious activity, 
intrinsic religiosity and the strength of religious faith.  
 
Patients and methods 
Study design and flow 
This cross-sectional study was performed at the Department of Psychiatry, University 
Hospital Center Zagreb, Croatia. It was approved by the institutional Ethics Committee 
and by the Ethics Committee of the Zagreb University School of Medicine. After 
confirmation of the respective diagnosis (MDD, or schizophrenia) and assessment of 
symptom severity by two independent licensed psychiatrists (researchers MŠ and AMP; 
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certified for the use of the employed instruments), patients were evaluated for several 
aspects of religiosity by a third investigator (LK). 
Patients 
Consecutive patients were diagnosed according to the DSM-IV criteria using the 
Structured Clinical Interview for Mental Disorders (SCID 1.0) and were included in the 
study if aged 18-65 years and had provided a written informed consent. Exclusion 
criteria were: a) intellectual disability, dementia or other cognitive disorder; b) past or 
current diagnosis of post-traumatic stress disorder; c) severe symptoms which would 
hinder conduction of the interview (e.g., catatonia, aggressive behavior); d) substance 
dependence or abuse within the past three months (except for nicotine and caffeine); e) 
any severe comorbid somatic/neurological disorder (uncontrolled hypertension, history 
of or present symptomatic coronary / peripheral artery disease, stroke or transitory 
ischemic attack, malignancy, chronic heart or renal failure, HIV, hepatitis, or any 
neurodegenerative disease); f) for patients with MDD – presence of psychotic symptoms 
(by SCID), for patients with schizophrenia – comorbid affective disorders (by SCID), 
religious delusions or first-episode psychosis. 
Measures of psychopathology 
Patients with MDD were evaluated using the Hamilton Rating Scale for Depression-17 
item version (HAM-D) (Hamilton et al., 1967). It is a clinician-rated instrument designed 
to quantify severity of depressive symptoms over the past week. Higher scores indicate 
more severe symptoms (minimum =0, maximum=50) (Hamilton et al., 1967). It is one of 
the most widely used rating scales for depression, and has been extensively used in 
Croatian population (e.g., Šagud et al., 2018).  
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Patients with schizophrenia were assessed by a structured interview for the Positive 
and Negative Syndrome Scale (PANSS) (Kay et al., 1987). It is a 30-item clinician-rated 
instrument that quantifies the severity of psychopathology. Each item is rated from 1 to 
7, and higher score=more severe psychopathology: 7 items rate positive symptoms and 
7 rate negative symptoms (minimum=7, maximum=49 for each symptom subset), and 
16 items rate general psychopathology (minimum=16, maximum=112) (Kay et al., 
1987). PANSS is the most established instrument for quantification of symptoms in 
patients with schizophrenia, and is commonly used in Croatian patients as well (e.g., 
Vlatković et al., 2018).  
All patients were rated by the Clinical Global Impression – Severity (CGI-S). It is a 
clinician-rated (from 1=patient is not at all ill, to 7=among most extremely ill patients) 
assessment of the overall severity of the disease (Guy et al., 1976). This scale has been 
commonly used in daily practice and for research purposes in Croatian patients (e.g., 
Vuksan-Ćusa et al, 2018).  
Measures of religiosity 
All patients were assessed using three self-reporting instruments: Duke University 
Religion index (DUREL) (Koenig & Bussing 2010), Santa Clara Strength of Religious Fate 
(SCSORF) questionnaire (Plante & Boccaccini 1997) and brief Religious Coping (RCOPE) 
scale (Pargament et al., 1998). 
DUREL is a 5-item scale that quantifies three aspects of religiosity (higher scores 
indicate higher religious involvement): a) “organizational” religious activity (one 
question, scored 1-6), ORA, b) “non-organizational” religious activity, NORA (one 
question, scored 1-6), c) intrinsic religiosity (IR) (three questions, each scored 1-5), for a 
total score range 5-27. It has been used for investigative purposes in different 
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populations, including psychiatric patients (Koenig & Bussing 2010). Croatian version of 
DUREL has already been published (Mihaljević et al., 2016).  
SCSORF is a 10-item scale (each rated 1-4) that assesses strength of religious faith 
regardless of religious denomination (higher score=stronger religious faith) (Plante & 
Boccaccini 1997). Croatian version of SCSORF has already been published (Aukst-
Margetić et al., 2015).  
Brief RCOPE is a 14-item instrument that quantifies the level of religious coping with 
major life stressors. It assesses two patterns of religious coping, positive (RCOPE-P; 
refers to seeking spiritual support, religious forgiveness, spiritual connection 
collaborative religious coping and purification, benevolent religious reappraisal and 
focus) and negative (RCOPE-N; refers to spiritual and interpersonal religious disconnect, 
punishing God reappraisals, demonic reappraisal and reappraisal of God’s power), each 
assessed through 7 items (each rated 1-4), for a minimum of 7 and a maximum of 28 
points, where higher score means a higher positive/negative coping pattern (Pargament 
et al., 1998). Croatian version of RCOPE has been published (Mihaljević et al., 2012). 
Outcome measures 
We used total HAM-D score as a measure of depressive symptoms, total PANSS and 
separately positive and negative symptom scores as measures of psychotic symptoms, 
DUREL subscales (ORA, NORA, IR) individually, SCSORF score and RCOPE-P and RCOPE-
N scores. For an approximate comparison of disease severity between MDD and 
schizophrenia patients, HAM-D and PANSS scores were projected to a 0-100 scale by 
linear transformation. Standardized scores (mean=0, standard deviation=1) were used 
in some analyses either as adjustments or as a dependent variable. 
Statistical analysis 
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Considering the cross-sectional design and exploratory nature of the study, we 
performed several analyses: a) relationships between measures of religiosity/religious 
coping were assessed by partial correlations; b) differences between MDD and 
schizophrenia patients in measures of religiosity were assessed as unadjusted 
differences and as adjusted differences in a multivariate analysis of variance; c) to 
explore the relationship in a “reverse” direction, measures of religiosity were considered 
as independents in a logistic model fitted to the binary outcome “diagnosis”; d) to 
evaluate the relationship between measures of religiosity and symptoms severity 
general linear models were fitted separately in MDD patients (to HAM-D) and in 
schizophrenia patients (to total PANSS and separately to positive and negative symptom 
scores). Since different associations were observed in the two diseases, models were re-
fitted to standardized symptom scores and included the interaction terms between 
diagnosis and religiosity measures; e) based on the above analyses, we generated 
hypotheses about specific mediated associations between SCSORF and symptom 
severity that were tested by mediation analysis. We used SAS 9.4 for Windows (SAS Inc., 
Cary, NC, USA) software for data analysis. 
 
Results 
Patient characteristics 
A total of 50 MDD patients (moderately depressed, median HAM-D score 17) and 50 
patients with schizophrenia (moderate symptoms, median PANSS score 119, similar for 
positive and negative symptoms) were enrolled (Table 1). Their sociodemographic 
characteristics were generally typical for the two diseases, virtually all declared 
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themselves as practicing Catholics, and raw scores indicated no major difference in any 
of the measures of religiosity between the two patient subsets (Table 1). 
Relationships between measures of religiosity and religious coping 
As illustrated by partial correlations (adjusted for age, sex, history of disease/treatment, 
history of suicidal thoughts/attempts and symptom severity), the relationships between 
measures of religiosity and measures of religious coping were closely similar in MDD 
and schizophrenia patients (Table 2): DUREL subscales (ORA, NORA and IR) were 
positively correlated with each other, but were inversely correlated with SCSORF and 
positive RCOPE, with no clear association with the negative RCOPE score (Table 2); 
SCSORF was positively correlated with positive RCOPE and weakly (low coefficients) 
with negative RCOPE, while positive and negative RCOPE were positively correlated to 
each other (Table 2). 
Relationship between measures of religiosity/religious coping and diagnosis  
There was no independent association between the diagnosis and any of the measures 
of religiosity/religious coping as indicated by no relevant overall difference and no 
difference in any of the religiosity measures between MDD and schizophrenia patients in 
multivariate analysis of variance (Table 3, Model 1), and no association between the 
religiosity measures and probability of MDD in a “reverse” analysis (logistic regression) 
(Table 3, Model 2). 
Relationship between measures of religiosity/religious coping and disease severity 
Four general linear models with religiosity measures as independents (with further 
adjustments for age, sex, history of disease and whether living alone) were fitted to 
symptom scores: one in MDD patients (to HAM-D score) and three in schizophrenia 
patients (to total PANSS score, to positive and to negative symptoms scores) (Table 4): 
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a) in MDD, higher ORA and higher negative RCOPE scores were independently 
associated with higher HAM-D scores; b) no such associations were observed in 
schizophrenia patients regarding total PANSS and positive symptoms scores, while 
higher ORA was associated with lower negative symptom scores (Table 4). The same 
models re-fitted to standardized HAM-D and total or negative symptoms PANSS scores, 
with diagnosis as an additional independent and with interaction terms between 
measures of religiosity and diagnosis (Table 5) formally demonstrated that the 
association between ORA and symptom severity was conditional on diagnosis 
(significant diagnosis*ORA interaction). The interactions between diagnosis and RCOPE-
N were not statistically significant, however higher RCOPE-N was associated with higher 
symptom score in MDD patients, while no association was observed in schizophrenia 
patients (Table 5).   
Higher SCSORF score is indirectly associated with lower HAM-D score in MDD patients and 
with higher negative symptom score in schizophrenia patients 
We considered strength of religious faith as a trait that has its origins in the early(er) 
periods of life and could be viewed as an “inherent characteristic” that might drive other 
aspects of religious behavior, i.e., those captured by the DUREL index, as well as the 
abilities of positive or negative religious coping. Therefore, although SCSORF scores 
were not directly associated with symptom severity (Table 4), we hypothesized that 
SCSORF might be indirectly (“through” other manifestations of religiosity) associated 
with symptom severity in MDD patients as well as in schizophrenia patients, at least 
regarding negative symptoms (Figure 1, upper panel). To test the hypothesis, we 
performed mediation analyses separately in MDD patients and in schizophrenia 
patients: SCSORF score was considered an independent variable, ORA, NORA, IR and 
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RCOPE-P (all correlated with SCSORF, Table 2) were the assumed mediators and HAM-D 
/ negative symptoms score were dependent variables (Figure 1). Adjustments in both 
models were the same (age, sex, disease duration/history, RCOPE-N and living in a 
family). In both MDD (Figure 1, Model 1) and schizophrenia patients (Figure 1, Model 2), 
higher SCSORF score was comparably associated with lower ORA, NORA and IR scores 
and with a higher RCOPE-P score, and had no direct associations with the severity of 
symptoms (Figure 1). In MDD patients (Figure 1, Model 1), higher ORA was associated 
with higher HAM-D score, and higher SCSORF was indirectly, “through” the association 
with lower ORA, associated with lower HAM-D scores (indirect effect=-0.24 95% CI -
0.60, -0.02). In patients with schizophrenia (Figure 1, Model 2), higher ORA was 
associated with lower PANSS negative symptoms score, and higher SCSORF was 
indirectly, “through” the association with lower ORA, associated with higher PANSS 
scores (indirect effect= 0.20 95%CI 0.00, 0.72). Hence, MDD and schizophrenia 
patients apparently differed in the direction of association between ORA and symptom 
severity, as well as in the direction of indirect (through ORA) association between 
SCSORF and symptom severity. 
 
Discussion 
It is difficult to compare findings about relationships between such complex constructs 
like religiosity/religious coping and symptom severity across studies pertaining to 
different psychopathology and conducted in different cultural and religious contexts 
since these factors are likely to limit the generalizability of the individual observations. 
Present study is specific insofar that it explored these relationships simultaneously in 
patients with two distinct disorders, i.e., clinically manifest major depressive disorder 
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(MDD) or schizophrenia. However, its cultural and religious context is also specific, since 
it was conducted in a Central/Eastern European country in which 85.3% of the 
population declare themselves as practicing Roman Catholics (Croatian Bureau of 
Statistics, 2017) – a proportion practically identical to the prevalence of Catholics in 
both patient subsets – and which has gone through complex religious changes in the 
post-Communist era (Marinović Jarolimov & Zrinščak, 2006). Generalizability of the 
present observations is further limited by a relatively small sample size, possible 
incomplete control for confounding in multivariate models (due to a limited sample size) 
and the fact that MDD patients had to be free of psychotic symptoms, while 
schizophrenia patients had to be free of affective disorders and religious delusions. This 
latter inclusion criterion, however, enabled a clearer insight into the evaluated 
relationships in a “pure” moderately severe depression and/or psychosis, and detection 
of possible differences between the two conditions.  
The present observations are several-fold. There appeared no substantial difference 
between MDD patients and patients with schizophrenia in scores quantifying 
organizational (ORA), non-organizational (NORA) and intrinsic religiosity (IR) (elements 
of the DUREL index), strength of religious faith (SCSORF), and scores quantifying the 
level of religious coping (RCOPE), positive (positive religious coping, PRC) and negative 
(negative religious coping, NRC). The relationship between these measures and 
symptom severity, however, differed between the two diseases. As evidenced by the 
analysis separately in MDD and in schizophrenia patients, as well as by the analysis in all 
patients that formally tested moderation by diagnosis, higher ORA was associated with 
more severe symptoms in MDD and with less severe negative symptoms in 
schizophrenia; higher level of NRC was associated with more severe symptoms in MDD, 
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while no association with symptom severity was observed in schizophrenia. No other 
measure of religiosity/religious coping was associated with severity of symptoms in 
either disorder. To the best of our knowledge, there have been no reports on the 
relationship between ORA and symptom severity in patients hospitalized for MDD. 
Studies in somatically ill patients with no clinical depression reported either no 
association between ORA and depressive symptoms (Lee et al., 2017), or higher ORA 
was associated with less depression (Freire de Madeiros et al., 2017). Present data 
suggest that MDD patients with more severe symptoms might be more engaged in 
religious services, presumably seeking comfort and hope. The association between 
higher ORA and lower PANSS negative symptoms was observed also in patients with 
schizophrenia in remission (Triveni et al., 2017). In this population with very mild 
symptoms, however, higher scores on other DUREL subscales were also associated with 
lower total PANSS and negative symptoms (Triveni et al., 2017). On the other hand, in a 
sample of patients with various conditions (mood disorders without psychosis, different 
psychotic disorders, religious delusions, substance abuse), higher NORA and IR were 
associated with worse symptoms (i.e., delusions and hallucinations) (AbdelGawad et al., 
2017). Taken together, the present and published data indicate that the relationship 
between DUREL subscales and symptom severity in psychotic patients may depend on 
(co)morbidity and severity of the disease. Due to the cross-sectional study design, it 
remains unclear whether our patients with more severe negative symptoms attended 
religious services less frequently due to a lack of motivation/social withdrawal, or 
whether participation in such services had alleviated their symptoms.  
Although this was not formally tested, RCOPE-P scores in the present study were 
considerably higher than RCOPE-N scores in both MDD and schizophrenia patients 
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suggesting that they both used more PRC than NRC methods, an observation reported 
also by others in a number of different settings (Braam et al., 2014; Koenig et al., 2014; 
Nurasikin et al., 2012; Pargament et al., 1998). The association between higher NRC and 
more severe symptoms in MDD or in bipolar disorder has been reported from other 
cultural/religious settings, as well (Amadi et al., 2016; Bosworth et al., 2003; Dew et al., 
2010; Rosmarin et al., 2014). It was also observed in somatically ill patients and/or their 
caregivers (Amadi et al., 2016; Hebert et al., 2009; Ng et al., 2017; Pargament et al., 
1998; Park and Dornelas, 2011; Vitorino et al., 2017; Vitorino et al., 2018), and across 
different religious denominations (Braam et al., 2010; Pirutinsky et al., 2011). Several 
(Braam et al., 2014; Garcia et al., 2018; Krumrei et al., 2011), but not all (Bosworth et al., 
2003) longitudinal studies have suggested a bi-directional relationship between NRC 
and depression. NRC, often referred to as spiritual struggle (Rosmarin et al., 2013) 
deserves particular attention in patients with MDD. Namely, NRC can “feed” the negative 
content of rumination –contrary to what happens in PRC (Garcia et al., 2018). More 
severely depressed patients have the feeling that "the God has left them" and consider 
their disease as a punishment for something they have done or have failed to do. There 
is evidence that clinical interventions might alleviate such spiritual struggles (Bay et al., 
2008; Bolens et al., 2012; Revheim et al., 2010), and, importantly, improve NRC (Cronjé 
et al., 2017). The presently observed lack of association between PRC and severity of 
depression in MDD patients is in agreement with reports in MDD patients with a similar 
disease severity (Amadi et al., 2016; Koenig et al., 2014; Rosmarin et al., 2014). On the 
other hand, in patients who were mainly in remission (Bosworth et al., 2013), higher 
PRC was associated with lower depressive difficulties. Combined, data suggest that PRC 
might be protective in MDD patients during remission (Bosworth et al., 2003), but that 
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this relationship might be lost when symptoms become more pronounced (Koenig et al., 
2014; Rosmarin et al., 2014; the current study) and patients begin perceiving their 
disease as a punishment or abandonment.  The observed lack of association between 
either PRC or NRC and symptom severity in schizophrenia patients is in line with the 
observations in clinically manifest patients with schizophrenia, schizoaffective disorder 
or mood disorder with psychotic features (Rosmarin et al., 2013). The observed 
difference in NRC - symptom severity relationship in MDD and schizophrenia patients is 
likely due to the absence of psychotic symptoms in the present MDD sample. Psychotic 
(as were the current schizophrenia patients) patients do not have an insight into their 
illness, lack the sense of being ill and therefore have no reason to consider themselves 
punished (Misiak et al., 2016). In turn, they may gain the insight as psychotic symptoms 
improve (Misiak et al., 2016) and might be prone to NRC in remission (Triveni et al., 
2017). As in MDD, PRC might be protective in remitted patients with schizophrenia 
(Triveni et al., 2017), while this association might not hold in the acute exacerbation of 
psychosis (Rosmarin et al., 2013). Actually, religiosity may not be a fixed concept for a 
given individual. For example, religiousness has changed in about a third of the patients 
with schizophrenia during a three-year period, where some patients experienced 
positive and some experienced negative changes (Mohr et al., 2010). 
Finally, to our knowledge, no study so far assessed the relationship between strength of 
religious faith (SCSORF questionnaire) and symptom severity in acute MDD or 
schizophrenia patients. We observed no direct association between SCSORF scores and 
severity of symptoms, but mediation analysis (limited by the cross-sectional study 
design) suggested that strength of religious faith might be associated with disease 
severity indirectly, through its associations with other manifestations of religiosity (in 
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the present study, via ORA). In both diseases, higher SCSORF scores were associated 
with higher RCOPE-R scores (partial correlations, regressions), but only weak 
(correlation) or none (regressions) association was observed with RCOPE-N scores. It 
appears counterintuitive that SCSORF score was inversely associated with ORA, NORA 
and IR scores (correlations, regressions) in both MDD and schizophrenia patients, since 
positive correlations were reported in oncology patients and healthy subjects (Sherman 
et al., 2001). At least in part, this might be due to the specific cultural and religious 
context of the study. While religion (Catholicism) played an important role in 
preservation of the separate national identity (of Croatians) during the Communist era 
in the former country (Yugoslavia), the social role of religion has dramatically changed 
over the past 25 years and a number of dilemmas and debates have been raised about 
the “appropriate” role of religion in the modern society (Marinović Jerolimov & Zrinščak, 
2006). However, the present observations clearly emphasize the need for further 
evaluation of this tool in psychiatric patients. 
Conclusions 
Despite certain limitations, the present study in a sample of adult inpatients with MDD 
and schizophrenia, almost exclusively practicing Catholics, suggests different 
relationships between organizational religious activity and negative religious coping and 
severity of depressive/psychotic symptoms in the two diseases. Longitudinal studies are 
needed to evaluate the relationship between religiosity and psychopathology in 
different stages of MDD and schizophrenia. Given the importance of religion and 
spirituality for many patients, better understanding of these relationships might 
eventually contribute to improved disease outcomes. 
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Figure 1 Indirect (mediated) association between the strength of religious faith (Santa 
Clara Strength of Religious Faith, SCSORF, score) and severity of symptoms in patients with 
major depressive disorder (MDD) (Hamilton Depression Rating Scale, HAM-D, score) and 
severity of negative symptoms in patients with schizophrenia (SCH) (Positive And Negative 
Syndrome Scale, PANSS, negative symptom score). Upper panel illustrates the hypothesis, 
middle panel (Model 1) summarizes results of mediation analysis in major depression 
patients and lower panel (Model 2) summarizes results of mediation analysis in 
schizophrenia patients. All direct (full arrows) and indirect (dashed arrows) associations 
are adjusted for the same covariates, hence all are independent. All associations are 
depicted by true regression coefficients (95% CI) (black arrows and numbers if different 
from zero, gray otherwise), while P-values and covariate effects are omitted for clarity. 
ORA - organizational religious activity, NORA – non-organizational religious activity, IR – 
intrinsic religiosity, RCOPE-N – negative religious coping, RCOPE-P – positive religious 
coping. ORA, NORA and IR are subscales of the Duke University Religiosity index (DUREL). 
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Table 1 Patient characteristics overall and by diagnosis – major depressive disorder (MDD) 
or schizophrenia (SCH). Data are median (range) or count (percent), and differences (MDD-
SCH) are median or proportion differences with 95% confidence intervals (CI). 
  All  MDD  SCH  MDD–SCH (95% CI) 
N  100  50  50   
Disease duration (years)  10 (0.1-58)  9 (0.1-58)  10 (0.1-36)  1.8 (-2.0, 5.0) 
Age (years)  47.5 (20-86)  56 (22-86)  35 (20-60)  19 (14, 23) 
Men  45 (45.0)  13 (26.0)  32 (64.0)  -38.0 (-54.4, -18.8) 
Never married   34 (34.0)  7 (14.0)  27 (54.0)  -40.0 (-55.6, -22.1) 
Live alone (vs. family/other)  22 (22.0)  16.0 (32.0)  6 (12.0)  20.0 (3.8, 35.8) 
Unemployed (vs. 
employed/retired/study) 
 24 (24.0)  7 (14.0)  17 (34.0)  -20.0 (-36.2, -3.2) 
Education  elementary  15 (15.0)  8 (16.0)  7 (14.0)  2.0 (-12.6, 16.7) 
Religious denomination         
None - Atheist  9 (9.0)  5 (10.0)  4 (8.0)  2.0 (-10.4, 14.7) 
Catholic  87 (87.0)  43 (86.0)  44 (88.0)  -2.0 (-16.1, 12.0) 
Other (non-Muslim)  4 (4.0)  2 (4.0)  2 (4.0)  0.0 
HAM-D  ---  17 (2-31)  ---  --- 
PANSS - total  ---  ---  119 (74-168)  --- 
PANSS – positive   ---  ---  28 (17-39)  --- 
PANSS – negative   ---  ---  29 (10-44)  --- 
HAM-D/PANSS transformed  40 (3.8-77)  33 (3.8-60)  49 (24-77)  -16.6 (-21.0, -12.0) 
CGI-S  5 (3-7)  4.5 (3-6)  5 (3-7)  0.0 (-1.0, 0.0) 
Suicidal thoughts/attempts         
Never  42 (42.0)  22 (44.0)  20 (40.0)  4.0 (-15.2, 23.0) 
Have had thoughts  31 (31.0)  12 (24.0)  19 (38.0)  -14.0 (-31.5, 4.3) 
Attempted suicide  27 (27.0)  16 (32.0)  11 (22.0)  10.0 (-7.6, 27.2) 
DUREL - ORA  4 (1-6)  3 (1-6)  4 (1-6)  0.0 (-1.0, 0.0) 
DUREL - NORA  2 (1-6)  1 (1-6)  3 (1-6)  0.0 (-1.0, 0.0) 
DUREL - IR  7 (3-15)  7 (3-15)  7 (3-15)  0.0 (-2.0, 1.0) 
SCSORF  28.5 (10-40)  32 (10-40)  26 (10-40)  4.0 (-1.0, 9.0) 
RCOPE - positive  21 (7-28)  21 (7-28)  18 (7-28)  1.5 (-1.0, 5.0) 
RCOPE - negative   10 (7-25)  10 (7-25)  10 (7-22)  0.0 (-1.0, 2.0) 
CGI-S – clinical global impression – status, DUREL – Duke University religion Index (ORA – 
organizational religious activity, NORA – non-organizational religious activity, IR – intrinsic 
religiosity subscores); HAM-D – Hamilton Depression Rating Scale; PANSS – Positive and 
Negative Syndrome Scale; RCOPE – religious coping scale; SCSORF – Santa Clara Strength of 
Religious Faith Questionnaire
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Table 2 Partial correlations (adjusted for age, sex, history of disease/treatment, history of suicidal thoughts/attempts and 
symptom severity) between measures of religiosity (DUREL subscales ORA, NORA, IR and SCSORF) and religious coping 
(RCOPE, positive P or negative N) by diagnosis (major depression, MDD; or schizophrenia, SCH). Correlation coefficients are 
given with P-values (in brackets). 
  ORA  NORA  IR  SCSORF  RCOPE-P  RCOPE-N 
MDD patients             
ORA  ---  0.705 (<0.001)  0.658 (<0.001)  -0.731 (<0.001)  -0.645 (<0.001)  -0.302 (0.044) 
NORA  0.705 (<0.001)  ---  0.674 (<0.001)  -0.851 (<0.001)  -0.769 (<0.001)  -0.155 (0.308) 
IR  0.658 (<0.001)  0.674 (<0.001)  ---  -0.796 (<0.001)  -0.703 (<0.001)  -0.210 (0.167) 
SCSORF  -0.731 (<0.001)  -0.796 (<0.001)  -0.796 (<0.001)  ---  0.918 (<0.001)  0.220 (0.146) 
RCOPE-P  -0.645 (<0.001)  -0.703 (<0.001)  -0.703 (<0.001)  0.918 (<0.001)  ---  0.304 (0.042) 
RCOP-N  -0.302 (0.044)  -0.155 (0.308)  -0.210 (0.167)  0.220 (0.146)  0.304 (0.042)  --- 
SCH patients             
ORA  ---  0.588 (<0.001)  0.586 (<0.001)  -0.600 (<0.001)  -0.523 (<0.001)  -0.026 (0.863) 
NORA  0.588 (<0.001)  ---  0.711 (<0.001)  -0.876 (<0.001)  -0.798 (<0.001)  -0.195 (0.198) 
IR  0.586 (<0.001)  0.711 (<0.001)  ---  -0.714 (<0.001)  -0.651 (<0.001)  -0.099 (0.519) 
SCSORF  -0.600 (<0.001)  -0.876 (<0.001)  -0.714 (<0.001)  ---  0.903 (<0.001)  0.327 (0.028) 
RCOPE-P  -0.523 (<0.001)  -0.798 (<0.001)  -0.651 (<0.001)  0.903 (<0.001)  ---  0.463 (0.001) 
RCOP-N  -0.026 (0.863)  -0.195 (0.198)  -0.099 (0.519)  0.327 (0.028)  0.463 (0.001)  --- 
DUREL – Duke University Religiosity Index (ORA – organizational religious activity, NORA – non-organizational religious 
activity, IR – intrinsic religiosity subscores); HAM-D – Hamilton Depression Rating Scale; PANSS – Positive and Negative 
Syndrome Scale; RCOPE – religious coping scale; SCSORF – Santa Clara Strength of Religious Faith Questionnaire 
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Table 3 Assessment of independent associations between diagnosis (major depressive 
disorder, MDD or schizophrenia, SCH) and measures of religiosity (DUREL subscales ORA, 
NORA, IR and SCSORF) and religious coping (RCOPE, positive P or negative N). Model 1 
–measures of religiosity and religious coping were simultaneous dependent variables in a 
multivariate analysis of variance to determine differences between MDD and SCH patients 
(adjusted for age, sex, history of disease/treatment, history of suicidal thoughts/attempts, 
living alone and disease severity standardized HAM-D and total PANSS scores). Model 2 – 
a logistic model was fitted to diagnosis as a binary dependent variable to evaluate whether 
any of the measures of religiosity/religious coping was associated with the diagnosis (same 
adjustments as above). Effects are adjusted odds ratios (OR). 
Model 1 (overall diagnosis effect P=0.807)  MDD – SCH (95% CI)  P 
ORA  0.35 (-0.42, 1.13)  0.368 
NORA  -0.23 (-1.20, 0.74)  0.642 
IR  -0.02 (-1.98, 1.94)  0.982 
SCSORF  1.33 (-3.73, 6.38)  0.604 
RCOPE-P  1.00 (-2.43, 4.23)  0.563 
RCOP-N  0.46 (-1.93, 2.84)  0.703 
Model 2 (probability of diagnosis=MDD)  OR (95% CI)  P 
ORA  1.48 (0.88-2.50)  0.138 
NORA  0.90 (0.48-1.71)  0.752 
IR  1.02 (0.80-1.30)  0.869 
SCSORF  1.04 (0.86-1.26)  0.680 
RCOPE-P  1.00 (0.81-1.25)  0.975 
RCOP-N  1.01 (0.88-1.14)  0.927 
DUREL – Duke University Religiosity Index (ORA – organizational religious activity, NORA – 
non-organizational religious activity, IR – intrinsic religiosity subscores); HAM-D – 
Hamilton Depression Rating Scale; PANSS – Positive and Negative Syndrome Scale; RCOPE – 
religious coping scale; SCSORF – Santa Clara Strength of Religious Faith Questionnaire
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Table 4 Assessment of independent associations between measures of religiosity – organizational (ORA) and non-
organizational (NORA) religious activity, intrinsic religiosity (IR), strength of religious faith (SCSORF) and positive (P) or 
negative (N) religious coping (RCOPE) – and severity of symptoms (HAM-D score) in patients with major depressive disorder 
(MDD) and in patients with schizophrenia (SCH) (total PANSS score, positive and negative symptoms scores). A separate 
general linear model was fitted to each of the four measures of symptom severity (further adjustments for age, sex, history of 
disease/treatment and whether living alone).  
  MDD: HAM-D score  SCH: total PANSS score  SCH: positive symptoms  SCH: negative symptoms 
  Estimate (95% CI)  P  Estimate (95% CI)  P  Estimate (95% CI)  P  Estimate (95% CI)  P 
SCSORF (by 1 point)  0.26 (-0.36, 0.88)  0.408  -0.53 (-2.42, 1.35)  0.570  -0.26 (-0.75, 0.23)  0.292  -0.31 (-0.98, 0.35)  0.346 
ORA (by 1 point)   2.28 (0.37, 4.19)  0.020  -2.84 (-8.37, 2.70)  0.306  -0.39 (-1.83, 1.05)  0.587  -1.99 (-3.94, -0.03)  0.046 
NORA (by 1 point)   -0.41 (-2.35, 1.53)  0.671  3.00 (-4.36, 10.4)  0.414  0.74 (-1.17, 2.66)  0.437  0.49 (-2.12, 3.09)  0.707 
IR (by 1 point)   -0.02 (-0.82, 0.78)  0.958  0.73 (-1.68, 3.10)  0.545  -0.27 (-0.90, 0.36)  0.395  0.75 (-0.10, 1.60)  0.082 
RCOPE-P (by 1 point)  -0.09 (-0.84, 0.65)  0.802  1.27 (-1.03, 3.57)  0.272  0.40 (-0.20, 1.00)  0.182  0.52 (-0.30, 1.33)  0.206 
RCOPE-N (by 1 point)  0.43 (0.03, 0.84)  0.037  0.54 (-1.25, 2.32)  0.548  0.02 (-0.44, 0.49)  0.927  0.12 (-0.51, 0.75)  0.699 
HAM-D – Hamilton Depression Rating scale; PANSS – Positive and Negative Syndrome Scale 
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Table 5 Association of organizational religious activity (ORA) and of negative religious 
coping (RCOPE-N) with symptom severity is conditional on diagnosis (major depressive 
disorder or schizophrenia). Models from Table 4 were re-fitted to standardized HAM-D and 
total or negative PANSS scores considering all patients, with diagnosis as an additional 
independent and with interaction terms between diagnosis and each of the indicators of 
religiosity/religious coping. Estimates are shown only for diagnosis*ORA and 
diagnosis*RCOPE-N interactions. In line with models fitted separately to MDD and 
schizophrenia patients (Table 4), no other associations were observed. 
Model 1 - standardized HAM-D and total PANSS  Estimate (95% CI)  P 
Diagnosis*ORA interaction   0.52 (0.12, 0.91)  0.011 
ORA in major depressive disorder patients  0.35 (0.05, 0.66)  --- 
ORA in schizophrenia patients  0.17 (-0.16, 0.51)  --- 
Diagnosis*RCOPE-N interaction  0.04 (-0.06, 0.15)  0.397 
RCOPE-N in major depressive disorder patients  0.06 (0.00, 0.12)  --- 
RCOPE-N in schizophrenia patients  0.02 (-0.06, 0.09)  --- 
Model 2 - standardized HAM-D and PANSS negative symptoms     
Diagnosis*ORA interaction   0.64 (0.26, 1.03)  0.001 
ORA in major depressive disorder patients  0.35 (0.05, 0.66)  --- 
ORA in schizophrenia patients  -0.29 (-0.54, -0.05)  --- 
Diagnosis*RCOPE-N interaction  0.05 (-0.05, 0.15)  0.331 
RCOPE-N in major depressive disorder patients  0.06 (0.00, 0.12)  --- 
RCOPE-N in schizophrenia patients  0.01 (-0.07, 0.09)  --- 
HAM-D – Hamilton Depression Rating scale; PANSS – Positive and Negative Syndrome Scale 
 
